Viron, Inc.

Boston, United States

Viron is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid is under FDA review.

$6.0M raised

Jun 2022

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Viron, Inc.

How much funding has Viron, Inc. raised?

Viron, Inc. has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2022.

Where is Viron, Inc. headquartered?

Viron, Inc. is headquartered in Boston, United States.

What does Viron, Inc. do?

Viron is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid is under FDA review.

What stage is Viron, Inc. at?

Viron, Inc. is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 23, 2022.

MLA

"Viron, Inc. — Funding & Investors." VCBacked, June 23, 2022, https://www.vcbacked.co/company/viron-inc. Accessed July 4, 2026.

APA

VCBacked. (2022). Viron, Inc. — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/viron-inc

Wikipedia (cite web)

{{cite web |title=Viron, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/viron-inc |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 23, 2022.